Currently, patients who have had a kidney transplant must take a cocktail of pills every day for the rest of their lives. These standard immunosuppressants prevent the immune system from attacking the ...

Please provide your email address to receive an email when new articles are posted on . In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed.

Chlorthalidone appears as effective as hydrochlorothiazide in slowing progression to chronic kidney disease among patients with hypertension. Kidney function decline occurs no faster when patients ...

Medically reviewed by Robert Burakoff, MD Key Takeaways Stage 1 CKD often doesn't cause noticeable symptoms but requires ...

A research team led by Prof. Dr. Christian Hinze, senior physician at the MHH Clinic for Kidney and Hypertension Diseases at ...

In this analysis of patients with myeloperoxidase-ANCA-positive AAV, all urinary complement C3 fragment levels were elevated significantly compared with healthy controls (P <.01 for all).

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

This Rare Disease Day, observed on Feb. 28 worldwide, the American Kidney Fund is committed to improving the understanding of ...

Forbes contributors publish independent expert analyses and insights. Dr. Lipi Roy writes about addiction, mental health and entertainment. Outside the respiratory system, the kidneys are among the ...

A new study offers hope that kidney transplant patients could one day have a monthly treatment instead of multiple pills ...